{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:30:49Z","timestamp":1766050249354,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Scientific Research Foundation of Southwest Medical University","award":["2018-ZRZD-019","2018-ZRZD-017"],"award-info":[{"award-number":["2018-ZRZD-019","2018-ZRZD-017"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902890"],"award-info":[{"award-number":["81902890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long intergenic non-coding RNA 326 (LINC00326) modulates hepatocarcinogenic lipid metabolism. However, the ability of LINC00326 to modulate the highly aggressive non-small cell lung carcinoma (NSCLC) is unknown. Here, LINC00326 in NSCLC was investigated, together with its effects on tumor malignancy and the underlying mechanisms of action.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>LINC00326 levels in tumor tissues and cell lines were measured by Real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) and RNA fluorescence in situ hybridization (FISH). Proliferation and apoptosis were assessed in cell lines by Cell Counting Kit-8 (CCK-8), EdU staining assays and flow cytometry, respectively, and tumor growth was measured in mouse models. Possible microRNA targets of LINC00326 were predicted by bioinformatics and verified by RNA pull-down and immunoprecipitation and luciferase reporter assays. Western blotting was used to evaluate the expression of Wnt\/\u03b2-catenin-associated proteins.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>\u00a0LINC00326 was downregulated in tumor tissues and cell lines. Knockdown of LINC00326 stimulated NSCLC cell proliferation and suppressed apoptosis in vitro<jats:italic>,<\/jats:italic> as well as enhancing xenograft tumor growth. LINC00326 sponged miR-657, and dickkopf WNT signaling pathway inhibitor 2 (DKK2) was found to be directly targeted by miR-657, with LINC00326 positively regulating its expression through sponging miR-657. The actions of LINC00326 knockdown on proliferation and apoptosis were reversed by stimulation of the miR-657\/DKK2 axis. Furthermore, overexpression of miR-657 mitigated DKK2 inhibition on Wnt\/\u03b2-catenin signaling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>LINC00326\/miR-657\/DKK2 axis signaling blocked tumor-associated functions in NSCLC cells through the targeting Wnt\/\u03b2-catenin pathway. This suggests that this pathway could be a target for NSCLC treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13062-023-00359-9","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T07:03:06Z","timestamp":1675666986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Upregulation of long intergenic non-coding RNA LINC00326 inhibits non-small cell lung carcinoma progression by blocking Wnt\/\u03b2-catenin pathway through modulating the miR-657\/dickkopf WNT signaling pathway inhibitor 2 axis"],"prefix":"10.1186","volume":"18","author":[{"given":"Yingqian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"issue":"148","key":"359_CR1","first-page":"167","volume":"27","author":"S Jonna","year":"2019","unstructured":"Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med. 2019;27(148):167\u201370.","journal-title":"Discov Med"},{"issue":"7689","key":"359_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"1","key":"359_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"359_CR4","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623\u201340.","journal-title":"Mayo Clin Proc"},{"key":"359_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2019.08.021","volume":"61","author":"F Abbas-Aghababazadeh","year":"2020","unstructured":"Abbas-Aghababazadeh F, Mo Q, Fridley BL. Statistical genomics in rare cancer. Semin Cancer Biol. 2020;61:1\u201310.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"359_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"3","key":"359_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/nrd.2016.117","volume":"16","author":"M Matsui","year":"2017","unstructured":"Matsui M, Corey DR. Non-coding RNAs as drug targets. Nat Rev Drug Discov. 2017;16(3):167\u201379.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"359_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37(3):270\u201388.","journal-title":"Cancer Cell"},{"key":"359_CR9","unstructured":"Dvorska D, Brany D, Nachajova M, Halasova E, Dankova Z. Breast cancer and the other non-coding RNAs. Int J Mol Sci. 2021;22(6)."},{"issue":"1","key":"359_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11427-020-1700-9","volume":"64","author":"PE Saw","year":"2021","unstructured":"Saw PE, Xu X, Chen J, Song EW. Non-coding RNAs: the new central dogma of cancer biology. Sci China Life Sci. 2021;64(1):22\u201350.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"359_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-020-01171-z","volume":"19","author":"X Zhang","year":"2020","unstructured":"Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, et al. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 2020;19(1):47.","journal-title":"Mol Cancer"},{"issue":"3","key":"359_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.ygyno.2021.03.020","volume":"161","author":"N Rahimian","year":"2021","unstructured":"Rahimian N, Razavi ZS, Aslanbeigi F, Mirkhabbaz AM, Piroozmand H, Shahrzad MK, et al. Non-coding RNAs related to angiogenesis in gynecological cancer. Gynecol Oncol. 2021;161(3):896\u2013912.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"359_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-019-0773-y","volume":"12","author":"Q Hua","year":"2019","unstructured":"Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p\/c-Myc axis. J Hematol Oncol. 2019;12(1):91.","journal-title":"J Hematol Oncol"},{"key":"359_CR14","doi-asserted-by":"crossref","unstructured":"Sun J, Zhang Z, Bao S, Yan C, Hou P, Wu N, et al. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020;8(1).","DOI":"10.1136\/jitc-2019-000110"},{"issue":"22","key":"359_CR15","first-page":"5135","volume":"21","author":"F Wang","year":"2017","unstructured":"Wang F, Chen JG, Wang LL, Yan ZZ, Chen SP, Wang XG. Up-regulation of LINC00346 inhibits proliferation of non-small cell lung cancer cells through mediating JAK-STAT3 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(22):5135\u201342.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"359_CR16","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10735-021-09981-1","volume":"52","author":"H Xia","year":"2021","unstructured":"Xia H, Niu Q, Ding Y, Zhang Z, Yuan J, Jin W. Long non-coding HOXA11-AS knockdown suppresses the progression of non-small cell lung cancer by regulating miR-3619-5p\/SALL4 axis. J Mol Histol. 2021;52(4):729\u201340.","journal-title":"J Mol Histol"},{"issue":"3","key":"359_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3892\/ol.2021.12471","volume":"21","author":"C Zhang","year":"2021","unstructured":"Zhang C, Gong C, Li J, Tang J. Downregulation of long non-coding RNA LINC-PINT serves as a diagnostic and prognostic biomarker in patients with non-small cell lung cancer. Oncol Lett. 2021;21(3):210.","journal-title":"Oncol Lett"},{"key":"359_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109309","volume":"118","author":"G Zhang","year":"2019","unstructured":"Zhang G, Wang Q, Zhang X, Ding Z, Liu R. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761\/TIMP2 axis. Biomed Pharmacother. 2019;118: 109309.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"359_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12958-020-00660-6","volume":"18","author":"M Joshi","year":"2020","unstructured":"Joshi M, Rajender S. Long non-coding RNAs (lncRNAs) in spermatogenesis and male infertility. Reproduct Biol Endocrinol. 2020;18(1):103.","journal-title":"Reproduct Biol Endocrinol"},{"key":"359_CR20","unstructured":"Leaf-nosed bat. Encyclop\u00e6dia Britannica: Encyclop\u00e6dia Britannica Online; 2009."},{"issue":"5","key":"359_CR21","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","volume":"234","author":"K Saliminejad","year":"2019","unstructured":"Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451\u201365.","journal-title":"J Cell Physiol"},{"key":"359_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","volume":"98","author":"S Mishra","year":"2016","unstructured":"Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016;98:12\u201323.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"359_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1533","volume":"10","author":"JR Iacona","year":"2019","unstructured":"Iacona JR, Lutz CS. miR-146a-5p: Expression, regulation, and functions in cancer. Wiley Interdiscip Rev RNA. 2019;10(4): e1533.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"359_CR24","doi-asserted-by":"publisher","first-page":"3046379","DOI":"10.1155\/2019\/3046379","volume":"2019","author":"SS Lee","year":"2019","unstructured":"Lee SS, Cheah YK. The interplay between MicroRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression. J Immunol Res. 2019;2019:3046379.","journal-title":"J Immunol Res"},{"issue":"1","key":"359_CR25","doi-asserted-by":"publisher","first-page":"9024","DOI":"10.1038\/s41598-020-65920-2","volume":"10","author":"ZY Zhang","year":"2020","unstructured":"Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL, Guo SS. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p\/MAPK1 axis. Sci Rep. 2020;10(1):9024.","journal-title":"Sci Rep"},{"issue":"19","key":"359_CR26","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s00018-018-2877-x","volume":"75","author":"C Bica-Pop","year":"2018","unstructured":"Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci. 2018;75(19):3539\u201351.","journal-title":"Cell Mol Life Sci"},{"issue":"18","key":"359_CR27","first-page":"9453","volume":"24","author":"ZZ Ni","year":"2020","unstructured":"Ni ZZ, He JK, Tang X, Tao Z, Zhang Y, Xie B. Identification of ELAVL1 gene and miRNA-139-3p involved in the aggressiveness of NSCLC. Eur Rev Med Pharmacol Sci. 2020;24(18):9453\u201364.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"359_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2147\/IJN.S271976","volume":"16","author":"T Zhang","year":"2021","unstructured":"Zhang T, Zhang P, Li HX. CAFs-Derived Exosomal miRNA-130a confers cisplatin resistance of NSCLC cells through PUM2-dependent packaging. Int J Nanomedicine. 2021;16:561\u201377.","journal-title":"Int J Nanomedicine"},{"key":"359_CR29","doi-asserted-by":"crossref","unstructured":"Wang L, Cho KB, Li Y, Tao G, Xie Z, Guo B. Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer. Int J Mol Sci. 2019; 20(22).","DOI":"10.3390\/ijms20225758"},{"issue":"6","key":"359_CR30","doi-asserted-by":"publisher","first-page":"9105","DOI":"10.1002\/jcp.27587","volume":"234","author":"X Kong","year":"2019","unstructured":"Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105\u201317.","journal-title":"J Cell Physiol"},{"issue":"10","key":"359_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmedgenet-2015-103334","volume":"52","author":"X Qi","year":"2015","unstructured":"Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52(10):710\u20138.","journal-title":"J Med Genet"},{"issue":"41","key":"359_CR32","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017;36(41):5661\u20137.","journal-title":"Oncogene"},{"key":"359_CR33","doi-asserted-by":"crossref","unstructured":"Taniue K, Akimitsu N. The functions and unique features of LncRNAs in cancer development and tumorigenesis. Int J Mol Sci. 2021;22(2).","DOI":"10.3390\/ijms22020632"},{"key":"359_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111158","volume":"134","author":"C Xing","year":"2021","unstructured":"Xing C, Sun SG, Yue ZQ, Bai F. Role of lncRNA LUCAT1 in cancer. Biomed Pharmacother. 2021;134: 111158.","journal-title":"Biomed Pharmacother"},{"key":"359_CR35","doi-asserted-by":"crossref","unstructured":"Ginn L, Shi L, Montagna M, Garofalo M. LncRNAs in Non-Small-Cell Lung Cancer. Noncoding RNA. 2020;6(3).","DOI":"10.3390\/ncrna6030025"},{"key":"359_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2020.104411","volume":"114","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Shoorei H, Branicki W, Taheri M. Non-coding RNA profile in lung cancer. Exp Mol Pathol. 2020;114: 104411.","journal-title":"Exp Mol Pathol"},{"issue":"1","key":"359_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12885-019-5435-5","volume":"19","author":"F Esfandi","year":"2019","unstructured":"Esfandi F, Taheri M, Omrani MD, Shadmehr MB, Arsang-Jang S, Shams R, et al. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues. BMC Cancer. 2019;19(1):222.","journal-title":"BMC Cancer"},{"key":"359_CR38","doi-asserted-by":"crossref","unstructured":"Sondergaard JN, Sommerauer C, Atanasoai I, Hinte LC, Geng K, Guiducci G, et al. CCT3-LINC00326 axis regulates hepatocarcinogenic lipid metabolism. Gut. 2022.","DOI":"10.1136\/gutjnl-2021-325109"},{"key":"359_CR39","doi-asserted-by":"crossref","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2).","DOI":"10.1083\/jcb.202009045"},{"key":"359_CR40","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-biochem-062917-012708","volume":"89","author":"JL Rinn","year":"2020","unstructured":"Rinn JL, Chang HY. Long non-coding RNAs: molecular modalities to organismal functions. Annu Rev Biochem. 2020;89:283\u2013308.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"359_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1186\/s12885-019-5983-8","volume":"19","author":"RS Zhou","year":"2019","unstructured":"Zhou RS, Zhang EX, Sun QF, Ye ZJ, Liu JW, Zhou DH, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.","journal-title":"BMC Cancer"},{"issue":"1","key":"359_CR42","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12943-017-0680-1","volume":"16","author":"H Wang","year":"2017","unstructured":"Wang H, Huo X, Yang XR, He J, Cheng L, Wang N, et al. STAT3-mediated upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer metastasis by regulating SOX4. Mol Cancer. 2017;16(1):136.","journal-title":"Mol Cancer"},{"key":"359_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2021.04.002","volume":"509","author":"J Venkatesh","year":"2021","unstructured":"Venkatesh J, Wasson MD, Brown JM, Fernando W, Marcato P. LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack. Cancer Lett. 2021;509:81\u20138.","journal-title":"Cancer Lett"},{"key":"359_CR44","doi-asserted-by":"publisher","first-page":"4851214","DOI":"10.1155\/2019\/4851214","volume":"2019","author":"P Wang","year":"2019","unstructured":"Wang P, Wang Z, Liu G, Jin C, Zhang Q, Man S, et al. miR-657 promotes macrophage polarization toward M1 by targeting FAM46C in gestational diabetes mellitus. Mediators Inflamm. 2019;2019:4851214.","journal-title":"Mediators Inflamm"},{"issue":"5","key":"359_CR45","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/CAD.0000000000001308","volume":"33","author":"X He","year":"2022","unstructured":"He X, Feng Y. MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression. Anticancer Drugs. 2022;33(5):478\u201388.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"359_CR46","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/hep.26162","volume":"57","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yang L, Liu X, Chen W, Chang L, Chen L, et al. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways. Hepatology. 2013;57(5):1919\u201330.","journal-title":"Hepatology"},{"issue":"53","key":"359_CR47","doi-asserted-by":"publisher","first-page":"91270","DOI":"10.18632\/oncotarget.20441","volume":"8","author":"X Jin","year":"2017","unstructured":"Jin X, Guan Y, Sheng H, Liu Y. Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer. Oncotarget. 2017;8(53):91270\u201380.","journal-title":"Oncotarget"},{"issue":"1","key":"359_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/0008-5472.CAN-09-3153","volume":"70","author":"SK Patnaik","year":"2010","unstructured":"Patnaik SK, Kannisto E, Knudsen S, Yendamuri S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res. 2010;70(1):36\u201345.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"359_CR49","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0378-1119(02)01106-X","volume":"302","author":"B Mao","year":"2003","unstructured":"Mao B, Niehrs C. Kremen2 modulates Dickkopf2 activity during Wnt\/LRP6 signaling. Gene. 2003;302(1\u20132):179\u201383.","journal-title":"Gene"},{"issue":"11","key":"359_CR50","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11):1461\u201373.","journal-title":"Oncogene"},{"key":"359_CR51","unstructured":"Taciak B, Pruszynska I, Kiraga L, Bialasek M, Krol M. Wnt signaling pathway in development and cancer. J Physiol Pharmacol. 2018;69(2)."},{"issue":"5","key":"359_CR52","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/SLA.0000000000001928","volume":"264","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhao Y, Herbst A, Kalinski T, Qin J, Wang X, et al. miR-221 mediates chemoresistance of esophageal adenocarcinoma by direct targeting of DKK2 expression. Ann Surg. 2016;264(5):804\u201314.","journal-title":"Ann Surg"},{"key":"359_CR53","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1038\/ncomms9640","volume":"6","author":"L Fang","year":"2015","unstructured":"Fang L, Cai J, Chen B, Wu S, Li R, Xu X, et al. Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt\/beta-catenin signalling. Nat Commun. 2015;6:8640.","journal-title":"Nat Commun"},{"issue":"11","key":"359_CR54","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.bbadis.2011.06.015","volume":"1812","author":"A Yanagida","year":"2011","unstructured":"Yanagida A, Iwaisako K, Hatano E, Taura K, Sato F, Narita M, et al. Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells. Biochim Biophys Acta. 2011;1812(11):1403\u201311.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"359_CR55","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13046-021-02119-x","volume":"40","author":"R Wang","year":"2021","unstructured":"Wang R, Liu J, Li K, Yang G, Chen S, Wu J, et al. An SETD1A\/Wnt\/beta-catenin feedback loop promotes NSCLC development. J Exp Clin Cancer Res. 2021;40(1):318.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"359_CR56","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1083\/jcb.148.4.691","volume":"148","author":"GH Farr 3rd","year":"2000","unstructured":"Farr GH 3rd, Ferkey DM, Yost C, Pierce SB, Weaver C, Kimelman D. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J Cell Biol. 2000;148(4):691\u2013702.","journal-title":"J Cell Biol"},{"key":"359_CR57","unstructured":"Global Health Estimates: Life expectancy and leading causes of death and disablitiy [Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates."},{"issue":"1","key":"359_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, et al. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8(+) T cell exclusion. J Exp Clin Cancer Res. 2021;40(1):4.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00359-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-023-00359-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00359-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T02:06:52Z","timestamp":1675822012000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-023-00359-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,6]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1186\/s13062-023-00359-9","relation":{},"ISSN":["1745-6150"],"issn-type":[{"type":"electronic","value":"1745-6150"}],"subject":[],"published":{"date-parts":[[2023,2,6]]},"assertion":[{"value":"7 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Sichuan Cancer Hospital & Institute, Sichuan Cancer Center and was conducted following the Declaration of Helsinki (2013 revision). The patients provided informed written consent. All animal experiments were done in the animal laboratory center per the study protocol according to the NIH Guide for the Care and Use of Laboratory Animals, approved by the Animal Care and Use Committee of Sichuan Cancer Hospital & Institute, Sichuan Cancer Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}